Earlier this month Novavax reached an agreement with the Serum Institute of India to produce as many as 2 billion doses a year. The vaccine is expected to be brought online by mid-2021.Coronavirus vaccine update: Novavax begins Phase 3 trials of its COVID-19 vaccine in the UK, to enrol 10,000 participants
Earlier this month Novavax reached an agreement with the Serum Institute of India to produce as many as 2 billion doses a year. The vaccine is expected to be brought online by mid-2021.
Subscribe to:
Post Comments (Atom)
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The company#39;s vaccine candidate -Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - Natio...
No comments:
Post a Comment